Orthopaedic Manipulation in Treatment of Adolescent Idiopathic Scoliosis
Launched by CHINESE UNIVERSITY OF HONG KONG · Nov 25, 2022
Trial Information
Current as of January 21, 2025
Unknown status
Keywords
ClinConnect Summary
After being informed about the study and potential risk, all patients giving written informed consent will undergo a 0-week screening period to determine eligibility for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a single-blind manner(participant) in a 1:1 ratio to Manipulation Techniques Group or Control Group.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adolescents aged between 10 and 18 who can speak and read Chinese
- • 2. Fulfil the diagnostic criteria of scoliosis, i.e. Cobb's angle ≥ 10 degree
- • 3. Risser grade ranging from 0 to 4
- • 4. Informed consent agreement signed by both subject and their parents/guardians
- • 5. Able to participate in follow-up assessments
- Exclusion Criteria:
- • 1. History of spine surgery;
- • 2. Cobb's angle \>30 degrees
- • 3. Known to have severe respiratory or cardiovascular comorbidities; vertebral tumours and spinal canal abnormalities; Leukaemia, thrombocytopenia and other bleeding disorders
- • 4. Known to have cognitive impairment.
- • 5. Documented pregnancy
- • 6. Wearing brace within 1 month.
- • 7. Involved in other interventional clinical studies at the same time.
- • 8. Uncooperative during treatments
- • 9. Being assessed by investigators as unsuitable to participate.
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials